Medical Advisory Board

Central to Global Cancer Technology, INC is strategic direction is the identification and development of proprietary products and platform technologies to better meet identified clinical demand. The ScientificAdvisory Group plays a key role in meeting this objective. The charter for this Group is to work with the Global Cancer Technology, INC. and the Manufacturing Division to identify and advise on new proprietary devices and consider technologies with broad clinical applications. The following distinguished panel of Doctors serves in the capacity of a medical advisor to either the parent company or one of the developing subsidiaries.

Dr. Santosh Kesari is a board-certified neurologist and neuro-oncologist and is currently Chair, Department of Translational Neuro-Oncology and Neurotherapeutics, John Wayne Cancer Institute. He is also Director of Neuro-Oncology, Providence Saint John’s Health Center and Member, Los Angeles Biomedical Research Institute. Dr. Kesari is ranked among the top 1% of neuro-oncologists and neurologists in the nation, according to Castle Connolly Medical Ltd and an internationally recognized scientist and clinician. He is a winner of an Innovation Award by the San Diego Business Journal. He is on the advisory board of American Brain Tumor Association, San Diego Brain Tumor Foundation, Chris Elliott Fund, Nicolas Conor Institute, Voices Against Brain Cancer, and Philippine Brain Tumor Alliance. He has been the author of over 250 scientific publications, reviews, or books. He is the inventor on several patents and patent applications, and founder and advisor to many cancer and neurosciences focused biotech startups. Dr. Kesari graduated from University of Pennsylvania, School of Arts and Sciences in 1992 and earned a Ph.D. degree in molecular biology and a M.D. from the University of Pennsylvania, School of Medicine. He completed his residency in neurology at the Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School and his neuro-oncology fellowship at the Dana-Farber Cancer Institute in Boston. He was previously assistant professor of neurology at Harvard Medical School/Dana-Farber Cancer Institute/Brigham and Women’s Hospital and then professor of neurosciences at UC San Diego.

Applied Physics and Electrical Engineering from UCSD
Professor of Nano engineering and Electrical and Computer Engineering at UC San Diego. Internationally known expert in photonics, opto-electronics, and cancer nanotechnology. Dr. Sadik served as director of major research centers including NCI funded NanoTumor Center at UCSD. Specializes in cancer nanotechnology, in vivo imaging, optical systems and their interface with electronics and software.Dr. Sadik has been closely involved with 12startup companies as co-founder including Genoptix, Nanogen, OriMedix, Devacell, and Ziva.. He has authored more than 350 publications.

Organic Chemistry fromSan Diego State University & University of Erlangen.
Highly experienced polymer and organic chemist. Head of the Chemical Biology Program at the Moores Cancer Center at the UC San Diego School of Medicine and a Research Scientist in the Department of Neuroscience. Held senior  level positions at The Scripps Research Institute, Humboldt University Berlin Medical School, University of TuebingenChildrens’ Hospital, and Columbia University. Distinguished Research Fellow at TargeGen, a Founder and the Head of Research at Brunswick Biotechnetics, a Research Scientist at General Atomics, and a member of the Member- Macromolecular Chemistry Group at the Boeing Scientific Research Institute.and founder of Neuropore.

Radiation Biology at the University of Alberta.
Biomedical engineer, faculty member at UC San Diego Moores Cancer Center.  Specializes in medical devices and imaging, worked in academia and development stage pharmaceutical companies.  A U.S. National Research Council Associate at the U.S. DoD. MS in Biomedical Engineering, at George Washington University, and  worked in functional and structural neuroimaging research at NINDS, NIH Bethesda, MD.  Co-founded Engineered Medical Devices Inc., Lemma Pharmaceuticals.Member of the American Chemical Society, the Society for Neuro-Oncology, and the Whittaker Institute of Bioengineering.

Dr. Ted Dubinsky serves as the Lawrence A. Mack Endowed Professor of Radiology, Obstetrics and Gynecology, University of Washington School of Medicine and as the Editor in Chief of Ultrasound Quarterly.  Dr. Dubinsky is a well-published and highly recognized luminary in the field of High Intensity Focused Ultrasound, having authored over 100 published peer review papers. At the University of Washington, Dr. Dubinsky served as the Director of Body Imaging an Adjunct Associate Professor of Obstetrics and Gynecology. Dr. Dubinsky achieved his medical degree from the University of Maryland after graduating from Johns Hopkins University

Dr. Wolf is a world-renowned radiosurgery neurosurgeon who has performed more private practice brain cancer treatments with gamma knife radiosurgery than any other neurosurgeon in the world. A member of numerous professional organizations, including the American Medical Association, American Association of Neurological surgeons, and the International Brain Research Organization, Dr. Wolf is also a founding member of the International Radiosurgery Support Association.   Dr. Wolf has been the recipient of numerous grants and research awards.  He has acted as principal investigator for two clinical trials involving treatment for severe head injury, both of which were funded by the National Institutes of Health.  Also, the American College of Surgeons presented Dr. Wolf and his investigative team with a Research Award for an abstract detailing a lobectomy procedure. Widely published, Dr. Wolf has authored and co-authored numerous book chapters and journal articles on neurological surgery, including work published in Advances in Neurology and the Journal of Neurosurgery.  He has presented his research as an honored speaker and invited lecturer at many medical meeting and conferences around the world, such as the Annual Meeting of the American Association of Neurological Surgeons, the Society for Neuroscience and the International Stereotactic Radiosurgery Society. Dr. Wolf graduated summa cum laude from Yale Medical School and trained at the University of Minnesota Hospitals. Earlier in his career, Dr. Wolf served as chief of epilepsy and skull-base surgery at the University of Maryland and assistant professor of neurology and neurosurgery. He received his Gamma Knife training at Brown University. Dr. Wolf founded the Miami Neuroscience Center in 1993. Over the past two decades, he and his team have performed nearly 7,000 Gamma Knife surgeries, acquiring a level of expertise unmatched in the field. The team’s long-time collaboration also led to a number of medical breakthroughs. The team was the first to make extensive use of radiosurgery to manage multiple metastases. It was also one of the first to apply radiosurgery to treat large-sized benign tumors, and the first nationally to provide Gamma Knife treatments on an outpatient basis.

Professor Bognar graduated from Semmelweis University in 1982 and then obtained a specialist qualification in neurology and neurosurgery in 1986 and 1989, respectively. As of 2005, he has been director of the Clinic of Neurosurgery at the Centre of Medical and Health Sciences of Debrecen University, associate professor, as of 2006, professor. Apart from leading the Clinic, he is an external consultant in child neurosurgery at the Institute. His key area of specialization is the research and treatment of brain tumors. He is greatly experienced in the surgical treatment of cerebrospinal fluid (CSF) circulation disorders, in epileptic surgery and in the operative treatment of cranial deformities. Professor Bognar founded the Rotating Gamma Institute-Debrecen and placed the first Rotating Gamma System (RGS) in Eastern Europe. Professor Bognar lectures around the world on stereotactic radiosurgery.

In 1996 he joined fellowship program in Stereotactic Functional Neurosurgery and Radiosurgery at Stereotaxis and Gamma Knife centre, Fujieda Heisei Memorial Hospital, Shizuoka, Japan, under Dr. Tatsuo Hirai and Dr. Takaaki Takizawa, During this fellowship he participated in about 500 Gamma Knife Surgeries and Micro-recording assisted functional neurosurgery procedures for movement disorders. He learnt various aspects of stereotactic frame based and frameless neuro navigation. On return to India in 1997 he joined Vidyasagar Institute of Mental Health and Neuro Sciences [Vimhans] at New Delhi India as Consultant Neurosurgeon. In 1998 he established first Gamma Knife centre in a dedicated neuroscience centre in SAARC region. He was designated head of Gamma knife Surgery at Vimhans. He has experience of more than 2000 Gamma Knife Treatments collectively. He is the founder of the Asian Radiosurgery Conference and conducted first Asian Gamma Knife Training Program at Saitama Japan.

Dr. Takacs serves as an Associate Professor, Department Physics and Astronomy, Clemson University. He was an Associate Professor at the University of Debrecen Medical and Health Science Center. While there, he was instrumental in developing the EXPLORER 4Dâ treatment planning system, which is the core operating technology for the family of Rotating Gamma Systems. Dr. Takacs received his Doctorate in Atomic Physics at The University of Debrecen and completed a post Doctorial program in Plasma Radiation from the NIST in Gaithersburg Maryland.

President and CEO of Acoustic MedSystems, Inc. Everette C. Burdette, PhD, is President and CEO of Acoustic MedSystems, Inc., a company developing image-guided interventions for brachytherapy and localized therapies using high intensity ultrasound. He serves on the corporate boards of Provena Health System Central IL Region, Oncology Systems, Inc. and Acoustic MedSystems, Inc. previously; he was Vice President of Research and Clinical Design at Computerized Medical Systems (CMS) and President of the Image Guidance Division of CMS. He was President and Chief Executive Officer ofBurdette Medical Systems from its inception in 1997 until its acquisition by CMS in 2002. Dr. Burdette holds a PhD and MS degrees in Electrical Engineering and in Physics, and BS in Physics from the Georgia Institute of Technology. He was Director of Advanced Technology Development for Dornier Medical Systems, Inc., a Daimler-Benz company, 1992-97. He was President of Labthermics Technologies, Inc., a medical therapeutic equipment company, from 1986 to 1992. He was a faculty member at the University of Illinois at Urbana-Champaign, Emory University School of Medicine, and Georgia Tech. He has worked in the radiation oncology, hyperthermic oncology, ultrasound imaging, and urological fields for 27 years and prior to that worked in the development of radar systems and microwave devices for military applications for 7 years. He has managed the development of ultrasound and electromagnetic medical devices for therapeutic and diagnostic applications for 25 years. He has authored more than 170 technical reports and scientific publications and 7 book chapters, and holds 34 patents.

Scientific & Advisory Board Members

  • Dr. Ted Dubinsky
  • Dr. Santosh Kesari
  • Dr. Milan Makale
  • Dr. Wolf Wrasidlo
  • Dr. SadikEsener
  • Dr. Aizik Wolf
  • Prof. Laszlo Bognar
  • Dr. Maheep Gaur
  • Dr. Clif Burdette, PhD
  • Dr. EndreTakacs, PhD